902-430-5022
An Innovative Approach to Delivering Health Care To People With Pain & Addiction
Who We Are
Upcoming Continuing Professional Development Opportunities
Monthly Virtual Learning Webinar
September 2022 @ 7pm ADT: Stay tuned.
Alcohol Use Disorder & Benzodiazepine Workshop
November 25, 2022: Planning is currently underway for a full day workshop to discuss Alcohol Use Disorder and Benzodiazepine Use. Registration will open in September.
The Safer Opioid Prescribing Program
January 2023: This program assists physicians, nurse practitioners and medical residents in acquiring knowledge and skills in chronic pain management and opioid prescribing.
The program involves three live webinars and a full-day virtual workshop. Registration will open in October.
Motivational Interview Workshop
February 17-18, 2023: This two day in-person workshop will aim to develop primary care provider's capacity to rapidly engage and develop therapeutic alliance with those seeking services. Registration will open in September.
The Safer Opioid Prescribing Program
The Nova Scotia Health Authority’s AMN-P&A in partnership with Doctors Nova Scotia is pleased to offer the Safer Opioid Prescribing Program. Developed and presented by the University of Toronto, the course is evidence-based, free of industry conflicts of interest and available to physicians, medical residents and nurse practitioners who prescribe opioids.
News & Publications
07-04-2022
Are doctors still prescribing too many opioids?
A study led by a McGill university scientist suggests opioid painkillers are not always beneficial-and sometimes harmful-as patients recover from a minor surgery. Go to article
06-17-2022
Congratulations to former mentor and leader within the AMN Dr. John Fraser who was awarded the Canadian Medical Association Honorary Membership Award for his dedication and leadership providing care for Nova Scotians living with chronic pain, substance use disorder and homelessness. Read the announcement here
06-06-2022
Congratulations to our own Dr. Leisha Hawker who has been appointed Doctors Nova Scotia's new president. Read the announcement here
05-02-2022
The AMN-P&A is thrilled to partner with @Pain_Canada, a multi-stakeholder, national initiative bringing together diverse people, organizations, and perspectives to work towards dramatically improved systems of care for people with chronic pain. Learn more at paincanada.ca
03-31-2022
New Benzodiazepine Standard
Physicians are aware of the harmful effects of Benzodiazepines and Z-drugs when used long-term or in combination with opioids.
The profession has achieved significant improvement in prescribing Benzodiazepines and Z-Drugs, with a significant reduction in co-prescribing these medications with opioids. Prescribing is particularly challenging when caring for legacy patients and when attempting to taper dosages.
To offer support and direction to physicians, the College’s Council has recently approved a new Professional Standard Regarding Benzodiazepines and Z-Drugs. This new guidance was developed in consultation with stakeholders including Nova Scotia Health, Doctors NS, and CMPA.
AMN-P&A is Supported by
AMN-P&A is Endorsed by
07-05-2022
Congratulations to the Network's Clinical Advisor for Pain and Mentor Dr. Maureen Allen on her new appointment as the Prescription Monitoring Program's Medical Consultant.
